Objective: To report the outcomes of cats that underwent surgical correction for sialoceles.
Study Design: Multi-institutional retrospective cohort study.
Animals: Twenty-one client-owned cats.
The role of the gut microbiota and its interplay with host metabolic health, particularly in the context of type 2 diabetes mellitus (T2DM) management, is garnering increasing attention. Dipeptidyl peptidase 4 (DPP4) inhibitors, commonly known as gliptins, constitute a class of drugs extensively used in T2DM treatment. However, their potential interactions with gut microbiota remain poorly understood.
View Article and Find Full Text PDF